- NEWS
Cutting-edge CAR-T cancer therapy is now made in India — at one-tenth the cost
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 627, 709-710 (2024)
doi: https://doi.org/10.1038/d41586-024-00809-y
References
Radhakrishnan, V. S., Agrawal, N., Bagal, B. & Patel, I. Clin. Lymphoma Myeloma Leuk. 21, e85–e98 (2021).
Dwivedi, A. et al. Mol. Cancer Ther. 20, 846–858 (2021).
Jain, H. et al. ASH Annual Meeting & Exposition paper 185507 (American Society of Hematology, 2023).
Deadly brain cancer shrinks after CAR-T therapy — but for how long is unclear
First cell therapy for solid tumours heads to the clinic: what it means for cancer treatment
CAR-T therapy for multiple sclerosis enters US trials for first time
MEGA-CRISPR tool gives a power boost to cancer-fighting cells
Turbocharged CAR-T cells melt tumours in mice — using a trick from cancer cells
Cancer-fighting CAR-T cells could be made inside body with viral injection
‘It’s all gone’: CAR-T therapy forces autoimmune diseases into remission
The race to supercharge cancer-fighting T cells
Cancer treatments boosted by immune-cell hacking
Last-resort cancer therapy holds back disease for more than a decade
Engineered cell therapy for cancer gets thumbs up from FDA advisers
